School of Biotechnology
Proteomics

Bibliography — Mathias Uhlén

October 2010

Publications 2010 2009 2007–2008 1998–2006 1993–1997 1981–1992

334.
Rimini R, Schwenk JM, Sundberg M, Sjöberg R, Klevebring D, Gry M, Uhlen M, Nilsson P. (2009) Validation of serum protein profiles by a dual antibody array approach. J Proteomics.73(2): 252-66.
333.
Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, Bhaskaran N, Persson A, Uhlen M, Sangfelt O, Spruck C, Leibold EA, Wohlschlegel JA. (2009) Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 326(5953):718-21.
332.
Rockberg J, Uhlen M. (2009) Prediction of antibody response using recombinant human protein fragments as antigen. Protein Science 18(11):2346-55.
331.
Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlen M, Artursson P. (2009) Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos. 37(12):2275-83.
330.
Mulder J, Zilberter M, Spence L, Tortoriello G, Uhlen M, Yanagawa Y, Aujard F,Hökfelt T, Harkany T. (2009) Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons. Proc Natl Acad Sci U S A. [Epub ahead of print]
329.
Ponten F, Gry M, Fagerberg L, Lundberg E, Asplund A, Berglund L, Oksvold P, Björling E, Hober S, Kampf C, Navani S, Nilsson P, Ottosson J, Persson A, Wernerus H, Wester K, Uhlen M. (2009) A global view of protein expression in human cells, tissues and organs, Mol Syst Biol. 5:337.
328.
Jagi A, Brennan DJ, Ryden L, Magnusson K, Fernö M, Ståhl O, Borgquist S, Uhlen M, Landberg G, Påhlman S, Ponten F, Jirström K. (2009) Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol. 22(12):1564-74.
327.
Strömberg S, Agnarsdottir M, Magnusson K, Rexhepaj E, Bolander A, Lundberg E, Asplund A, Ryan D, Rafferty M, Gallagher WM, Uhlen M, Bergqvist M, Ponten F. (2009) Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. J Proteome Res. 8(4):1639-46.
326.
Gry M, Rimini R, Strömberg S, Asplund A, Ponten F, Uhlen M, Nilsson P. (2009) Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics. 10:365.
325.
Rockberg J, Schwenk JM, Uhlen M. (2009) Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies. Mol Oncol. 3 (3): 238-247.
324.
Aebersold R,et al (2009) Report on EU-USA workshop: how systems biology can advance cancer research. Mol Oncol.3(1):9-17.
323.
Mulder J, Björling E, Jonasson K, Wernerus H, Hober S, Hökfelt T, Uhlen M. (2009) Tissue profiling of the mammalian central nervous system using human antibody-based proteomics. Mol Cell Proteomics. 8(7):1612-22.
322.
Steen J, Ramström M, Uhlen M, Hober S, Ottosson J. (2009) Automated sample preparation method for mass spectrometry analysis on recombinant proteins. J Chromatogr A. 1216(20):4457-64.
321.
Rodriguez H, et al (2009) Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res. 8(7):3689-92.
320.
Jönsson HN, Samuels ML, Brouzes ER, Medkova M, Uhlen M, Link DR, Andersson-Svahn H. (2009) Detection and analysis of low-abundance cell-surface biomarkers using enzymatic amplification in microfluidic droplets. Angew Chem Int Ed Engl. 48(14):2518-21.
319.
Strömberg S, Agnarsdottir MT, Magnusson K, Rexhepaj E, Bolander S, Lundberg E, Asplund A, Ryan D, Rafferty M, Gallagher W, Uhlen M, Bergqvist M, Ponten F. (2009) Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma. J Proteome Res. In press
318.
Newberg JY, Li J, Rao A, Ponten F, Uhlen M, Lundberg E, Murphy RF. (2009) Automated Analysis of Human Protein Atlas Immunofluorescence Images. Proc IEEE Int Symp Biomed Imaging. 2009;5193229:1023-1026.
317.
Larsson K, Eriksson C, Schwenk JM, Berglund L, Wester K, Uhlen M, Hober S, Wernerus H. (2009) Characterization of PrEST-based antibodies towards human Cytokeratin-17. J Immunol Methods. 342(1-2):20-32.
316.
Tegel H, Steen J, Konrad A, Nikdin H, Pettersson K, Stenvall M, Tourle S, Wrethagen U, Xu L, Yderland L, Uhlen M, Hober S, Ottosson J. (2009) High-throughput protein production--lessons from scaling up from 10 to 288 recombinant proteins per week. Biotechnol J.4(1):51-7.
Last updated: 2010-12-22